Visby Medical Revenue and Competitors
Estimated Revenue & Valuation
- Visby Medical's estimated annual revenue is currently $35M per year.
- Visby Medical's estimated revenue per employee is $167,464
- Visby Medical's total funding is $383.7M.
- Visby Medical's current valuation is $1.1B. (March 2022)
Employee Data
- Visby Medical has 209 Employees.
- Visby Medical grew their employee count by 0% last year.
Visby Medical's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | SVP Quality, Regulatory and Clinical Affairs | Reveal Email/Phone |
3 | SVP Manufacturing and Operations | Reveal Email/Phone |
4 | SVP Research and Development | Reveal Email/Phone |
5 | Head Information Technology(CIO Scope) | Reveal Email/Phone |
6 | VP Finance | Reveal Email/Phone |
7 | Director Product Transfer | Reveal Email/Phone |
8 | Director Rewards & Employee Experience | Reveal Email/Phone |
9 | Sr. Director Engineering | Reveal Email/Phone |
10 | Director Assay | Reveal Email/Phone |
Visby Medical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 99 | -1% | $38.2M | N/A |
#2 | $35M | 209 | 0% | $383.7M | N/A |
#3 | $15M | 236 | 1% | $100M | N/A |
What Is Visby Medical?
Driven by a belief that results should be quick, accurate, and accessible to all, we are developing a device platform that aims to redefine the way we test and treat illness.
keywords:N/A$383.7M
Total Funding
209
Number of Employees
$35M
Revenue (est)
0%
Employee Growth %
$1.1B
Valuation
N/A
Accelerator
Visby Medical News
Visby Medical has secured additional funding of $25.5m from the US Biomedical Advanced Research and Development Authority (BARDA) to develop...
Visby said it designed its developmental-stage flu-COVID-19 PCR test as a single-use, handheld, all-in-one device for detecting and...
Visby Medical is accelerating the delivery of fast and accurate, palm-sized PCR diagnostics to the point of care, and eventually for use at home...
SAN JOSE, Calif., Sept. 13, 2021 /PRNewswire/ -- Visby Medical™ announced today that its instrument-free Reverse Transcription (RT)-Polymerase Chain Reaction (PCR) COVID-19 test was granted Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for testing pooled pati ...
SAN JOSE, Calif., Oct. 13, 2020 /PRNewswire/ -- Visby Medical™, an infectious disease diagnostic company, received Phase 2 funding from the National Institutes of Health (NIH) as part of its Rapid Acceleration of Diagnostics (RADx) initiative. The RADx initiative aims to combat SARS-CoV-2 and ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $42M | 209 | 1% | N/A |
#2 | $74.7M | 209 | -1% | N/A |
#3 | $7.5M | 210 | -9% | $127.8M |
#4 | $62.2M | 212 | -18% | $575.2M |
#5 | N/A | 212 | 3433% | N/A |